These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 31492175)
21. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples. Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738 [TBL] [Abstract][Full Text] [Related]
22. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer. Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858 [TBL] [Abstract][Full Text] [Related]
23. Screening for early pancreatic ductal adenocarcinoma in hereditary pancreatitis. Howes N; Greenhalf W; Neoptolemos J Med Clin North Am; 2000 May; 84(3):719-38, xii. PubMed ID: 10872428 [TBL] [Abstract][Full Text] [Related]
25. DNA Hypermethylation as a Blood-Based Marker for Pancreatic Cancer: A Literature Review. Henriksen SD; Madsen PH; Krarup H; Thorlacius-Ussing O Pancreas; 2015 Oct; 44(7):1036-45. PubMed ID: 26355546 [TBL] [Abstract][Full Text] [Related]
26. MeCP2 suppresses LIN28A expression via binding to its methylated-CpG islands in pancreatic cancer cells. Xu M; Bian S; Li J; He J; Chen H; Ge L; Jiao Z; Zhang Y; Peng W; Du F; Mo Y; Gong A Oncotarget; 2016 Mar; 7(12):14476-85. PubMed ID: 26910839 [TBL] [Abstract][Full Text] [Related]
27. Identification of tissue-specific cell death using methylation patterns of circulating DNA. Lehmann-Werman R; Neiman D; Zemmour H; Moss J; Magenheim J; Vaknin-Dembinsky A; Rubertsson S; Nellgård B; Blennow K; Zetterberg H; Spalding K; Haller MJ; Wasserfall CH; Schatz DA; Greenbaum CJ; Dorrell C; Grompe M; Zick A; Hubert A; Maoz M; Fendrich V; Bartsch DK; Golan T; Ben Sasson SA; Zamir G; Razin A; Cedar H; Shapiro AM; Glaser B; Shemer R; Dor Y Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1826-34. PubMed ID: 26976580 [TBL] [Abstract][Full Text] [Related]
28. DNA Methylation-Derived Immune Cell Profiles, CpG Markers of Inflammation, and Pancreatic Cancer Risk. Michaud DS; Ruan M; Koestler DC; Alonso L; Molina-Montes E; Pei D; Marsit CJ; De Vivo I; Malats N; Kelsey KT Cancer Epidemiol Biomarkers Prev; 2020 Aug; 29(8):1577-1585. PubMed ID: 32430337 [TBL] [Abstract][Full Text] [Related]
29. Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysis. Rajamani D; Bhasin MK Genome Med; 2016 May; 8(1):38. PubMed ID: 27137215 [TBL] [Abstract][Full Text] [Related]
30. Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived. Ueki T; Walter KM; Skinner H; Jaffee E; Hruban RH; Goggins M Oncogene; 2002 Mar; 21(13):2114-7. PubMed ID: 11960385 [TBL] [Abstract][Full Text] [Related]
31. Murine Models of Pancreatitis Leading to the Development of Pancreatic Cancer. Leal AS; Liby KT Curr Protoc Pharmacol; 2018 Dec; 83(1):e48. PubMed ID: 30325112 [TBL] [Abstract][Full Text] [Related]
35. Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group. Malats N; Casals T; Porta M; Guarner L; Estivill X; Real FX Gut; 2001 Jan; 48(1):70-4. PubMed ID: 11115825 [TBL] [Abstract][Full Text] [Related]
36. The molecular basis of pancreatic fibrosis: common stromal gene expression in chronic pancreatitis and pancreatic adenocarcinoma. Binkley CE; Zhang L; Greenson JK; Giordano TJ; Kuick R; Misek D; Hanash S; Logsdon CD; Simeone DM Pancreas; 2004 Nov; 29(4):254-63. PubMed ID: 15502640 [TBL] [Abstract][Full Text] [Related]
37. Integrative DNA methylome analysis of pan-cancer biomarkers in cancer discordant monozygotic twin-pairs. Roos L; van Dongen J; Bell CG; Burri A; Deloukas P; Boomsma DI; Spector TD; Bell JT Clin Epigenetics; 2016; 8():7. PubMed ID: 26798410 [TBL] [Abstract][Full Text] [Related]
38. Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancer. Whitcomb DC Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G315-9. PubMed ID: 15246966 [TBL] [Abstract][Full Text] [Related]
39. Positive regulation of human telomerase reverse transcriptase gene expression and telomerase activity by DNA methylation in pancreatic cancer. Kumari A; Srinivasan R; Vasishta RK; Wig JD Ann Surg Oncol; 2009 Apr; 16(4):1051-9. PubMed ID: 19194757 [TBL] [Abstract][Full Text] [Related]
40. Interleukin-6 in inflammatory and malignant diseases of the pancreas. Lesina M; Wörmann SM; Neuhöfer P; Song L; Algül H Semin Immunol; 2014 Feb; 26(1):80-7. PubMed ID: 24572992 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]